Research is at the heart of breakthroughs that bring more effective therapies to cancer patients and inform our understanding of the disease. Through innovative clinical research and trials, we are able to evaluate new drug, diagnostic, and other treatments to determine if they are safe and effective. These trials ultimately allow us to bring the latest and most effective therapies more quickly from the research bench to patients in treatment for the benefit of patients today and in the future. Each year, through our research efforts and collaborations, our patients have access to hundreds of clinical research trials that offer the most advanced treatment protocols before they are available to patients at other institutions.
Is a clinical trial right for you?
Dana-Farber and Brigham and Women's Hospital are founding members of Dana-Farber/Harvard Cancer Center. This research collaborative brings together leading cancer institutions Dana-Farber, Harvard Medical School, Harvard School of Public Health, Brigham and Women's Hospital, and three other Harvard-affiliated hospitals to form the largest comprehensive cancer center in the world. Through Dana-Farber/Harvard Cancer Center, hundreds more patients are being enrolled in clinical trials, innovative programs are expanding the field of knowledge and serving the public good, and shared facilities are resulting in cost efficiencies and scientific archives crucial to conducting world-class research.